First Opinion Lynne Moronski How to ensure the NIH’s decision to recognize people with disabilities as a health disparity population makes a difference
Special Report Sarah Owermohle HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy
In the Lab Jonathan Wosen NIH panel calls for fewer, better-paid postdocs in bid to halt loss of scientists to industry
Pharmalot Ed Silverman STAT Plus: In response to criticism, FDA publishes new database of wayward clinical trial sponsors
Politics Sarah Owermohle STAT Plus: Biden appoints Vanderbilt oncologist to head National Cancer Institute
Politics Rachel Cohrs Zhang STAT Plus: New NIH head says government has fallen behind pharma on clinical trials
Health tech Katie Palmer STAT Plus: With a new center, All of Us tackles health data silos to power precision medicine
Politics Sarah Owermohle STAT Plus: NIH confirmation hearing highlights just how divisive the agency’s portfolio has become
Politics Sarah Owermohle and Angus Chen STAT Plus: What to make of Biden’s latest Cancer Moonshot efforts
Politics John Wilkerson STAT Plus: NIH nominee Bertagnolli will get a confirmation hearing next month, Sanders says
First Opinion Mark J. Ratain The best way for the NIH to reduce drug prices is to address drug spending
Health Betsy Ladyzhets ‘Underwhelming’: NIH trials fail to test meaningful long Covid treatments — after 2.5 years and $1 billion
Politics Rachel Cohrs Zhang NIH begins long-delayed clinical trials for long Covid, announces new research office
Politics Sarah Owermohle STAT Plus: A new lobby shop looks to remind Congress about NIH’s translational research arm
In the Lab Brittany Trang STAT Plus: NIH fellows, weighing a union, want a pay raise. Will that mean less money for grants?
Politics Sarah Owermohle STAT Plus: Biden’s NIH nominee is languishing in Congress — alarming public health advocates
Pharmalot Ed Silverman STAT Plus: NIH halts funding for Colombian research facilities accused of abusing animals
Politics Helen Branswell STAT Plus: House GOP inquiry over gain-of-function research targets a scientific giant
Politics Brittany Trang STAT Plus: Doctors’ lobby doubles down on the fight against expanding open access to research
First Opinion Richard Joseph and Rachele Pojednic How to separate sound wellness solutions from seductive snake oil
Pharmalot Ed Silverman STAT Plus: Sanders wants NIH to adopt ‘reasonable pricing’ language for drugs that agency research helps develop
Politics Sarah Owermohle STAT Plus: Debt ceiling deal could mean cancer, disease research cuts, advocates warn
Politics Sarah Owermohle and Brittany Trang STAT Plus: New Biden science agency ARPA-H launches first program, targeting bone regrowth